Ondansetron Hameln

Ondondansetron, the active ingredient in Ondansetron Hameln, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Hameln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ondansetron is a selective  …  ...  …  …  …  ...  …  …  …  …  …  …  …  …  …

-  Chemotherapy  …  …  ...  ...  ...  …  …  ...  ...  …  ...  …  … ‑   …  …  …  ...  …   … ​  …  …  …  …  ​  …  …  …  …